BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21055712)

  • 1. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
    Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
    Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age.
    Bekeredjian R; Krumsdorf U; Chorianopoulos E; Kallenbach K; Karck M; Katus HA; Rottbauer W
    Am J Cardiol; 2010 Dec; 106(12):1777-81. PubMed ID: 21055715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.
    Stöhr R; Dohmen G; Herpertz R; Brehmer K; Aktug O; Koos R; Altiok E; Stegemann E; Autschbach R; Marx N; Hoffmann R
    Coron Artery Dis; 2011 Dec; 22(8):595-600. PubMed ID: 22009042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
    Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
    J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
    Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
    Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis.
    Gotzmann M; Bojara W; Lindstaedt M; Ewers A; Bösche L; Germing A; Lawo T; Bechtel M; Laczkovics A; Mügge A
    Am J Cardiol; 2011 Jun; 107(11):1687-92. PubMed ID: 21439537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.
    Nozohoor S; Nilsson J; Lührs C; Roijer A; Algotsson L; Sjögren J
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):161-5. PubMed ID: 19167912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation.
    Gotzmann M; Lindstaedt M; Bojara W; Mügge A; Germing A
    Am Heart J; 2010 May; 159(5):926-32. PubMed ID: 20435207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation.
    Ben-Dor I; Dvir D; Barbash IM; Okubagzi P; Torguson R; Xue Z; Lindsay J; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2012 Oct; 110(7):1008-14. PubMed ID: 22721576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
    Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
    Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.
    Gotzmann M; Pljakic A; Bojara W; Lindstaedt M; Ewers A; Germing A; Mügge A
    Am Heart J; 2011 Aug; 162(2):238-245.e1. PubMed ID: 21835283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term quality of life improvement after transcatheter aortic valve implantation.
    Georgiadou P; Kontodima P; Sbarouni E; Karavolias GK; Smirli A; Xanthos T; Troupis T; Khouri M; Papadimitriou L; Voudris V
    Am Heart J; 2011 Aug; 162(2):232-7. PubMed ID: 21835282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis.
    Hayashida K; Morice MC; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Lefèvre T
    J Am Coll Cardiol; 2012 Feb; 59(6):566-71. PubMed ID: 22300690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation.
    Gutiérrez M; Rodés-Cabau J; Bagur R; Doyle D; DeLarochellière R; Bergeron S; Lemieux J; Villeneuve J; Côté M; Bertrand OF; Poirier P; Clavel MA; Pibarot P; Dumont E
    Am Heart J; 2009 Aug; 158(2):302-8. PubMed ID: 19619709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery after balloon aortic valvuloplasty in patients with aortic stenosis and impaired left ventricular function: predictors and prognostic implications.
    Kefer J; Gapira JM; Pierard S; De Meester C; Gurne O; Chenu P; Renkin J
    J Invasive Cardiol; 2013 May; 25(5):235-41. PubMed ID: 23645048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry.
    Sinning JM; Horack M; Grube E; Gerckens U; Erbel R; Eggebrecht H; Zahn R; Linke A; Sievert H; Figulla HR; Kuck KH; Hauptmann KE; Hoffmann E; Hambrecht R; Richardt G; Sack S; Senges J; Nickenig G; Werner N
    Am Heart J; 2012 Jul; 164(1):102-10.e1. PubMed ID: 22795289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata.
    Tamburino C; Barbanti M; Capodanno D; Sarkar K; Cammalleri V; Scarabelli M; Mulè M; Immè S; Aruta P; Ussia GP
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):132-40. PubMed ID: 21538786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.